New York Times reporter, author of an article in today’s paper about Washington State lawmakers and their efforts to regulate of prescription painkillers.
Barry Meier appears in the following:
Wednesday, November 28, 2012
Wednesday, February 15, 2012
In 2009, the Food and Drug Administration rejected an artificial hip manufactured by Johnson & Johnson. However, the company continued to sell the hip replacement in Europe and marketed a related model stateside. More than 90,000 patients worldwide used these faulty devices, and resulted in painful corrective surgery for many. In the wake of an August 2010 recall and thousands of lawsuits, Johnson & Johnson has lost at least $3 billion.
Tuesday, October 04, 2011
Thursday, July 29, 2010
Today an FDA advisory panel meets with lawmakers to hammer out voluntary best practices for doctors who prescribe opiates. The regulation of opioid drugs like Oxycontin has loosened in recent years, as patient advocates asked for powerful narcotic painkillers for end-of-life care and cancer treatments. But in loosening restrictions for such cases, the FDA opened a window for wider prescriptions — and for abuse.